Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) Return on Sales (2024 - 2025)

Incannex Healthcare's Return on Sales history spans 2 years, with the latest figure at 5.45% for Q2 2025.

  • On a quarterly basis, Return on Sales changed N/A to 5.45% in Q2 2025 year-over-year; TTM through Jun 2025 was 5.45%, a N/A change, with the full-year FY2025 number at 5.45%, up 993.0% from a year prior.
  • Return on Sales hit 5.45% in Q2 2025 for Incannex Healthcare, down from 4.91% in the prior quarter.
  • Over the last five years, Return on Sales for IXHL hit a ceiling of 0.73% in Q3 2024 and a floor of 5.45% in Q2 2025.